Ion Beam Applications SA (OTCMKTS:IOBCF – Get Free Report)’s share price traded down 7.4% during mid-day trading on Wednesday . The stock traded as low as $16.85 and last traded at $16.85. 500 shares changed hands during trading, a decline of 4% from the average session volume of 520 shares. The stock had previously closed at $18.2050.
Ion Beam Applications Stock Down 7.4%
The business has a fifty day moving average of $17.24 and a 200 day moving average of $15.04.
Ion Beam Applications Company Profile
Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.
In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.
Read More
- Five stocks we like better than Ion Beam Applications
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Ion Beam Applications Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ion Beam Applications and related companies with MarketBeat.com's FREE daily email newsletter.
